Nuceiva™ (prabotulinumtoxinA) is a proprietary 900 kDa purified botulinum toxin type A formulation. Nuceiva™ treatment is almost the same as Botox® treatments as both are derived from the same base molecules. Nuceiva™ is a neurotoxin developed for only aesthetic purposes. Similar to other brands such as Botox and Dysport, Nuceiva™ works to neuromodulate or smooth out the creases in the face with a similar effectiveness. Botox® has a long clinical safety record. There have been no adverse complications from the use of Nuceiva™
Nuceiva™ was authorized for sale by Health Canada in August 2019. Nuceiva™ is produced by Evolus.com under strict quality and safety standards in a state-of-the art facility, specifically built for its manufacturing. Clarion Medical Technologies officially brought Nuceiva™ to the Canadian market in October 2019. In the United States, it is marketed as Jeuveau® It is also available in the European Union.
It is possible to switch from injectable Botox or Dysport neurotoxins to Nuceiva™ because of their same base molecule. Your decision is based on personal choice. If you are looking to save a bit of money, the slightly cheaper Nuceiva™ may prove to be the right injectable for your facial antiwrinkle treatments.
Nuceiva™ can be used to prevent certain muscle movements by relaxing those muscles under the skin in a variety of facial areas such as vertical lines between the eyes, crows feet and horizontal forehead lines. Nuceiva™ usually lasts about 3 to 4 months and can vary from person to person. The full effect usually takes about 7 to 10 days and some people report results as quickly as 24 to 72 hours.